Publications:

Spred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line.

Translational Cancer Research

He, Zhiyong Z; Gong, Fusheng F; Liao, Jinrong J; Wang, Qiang Q; Su, Ying Y; Chen, Chao C; Lin, Jinghui J; Lin, Ren-Jang RJ

Publication Date: 2020-04

Variant appearance in text: EGFR: 1081delA

PubMed Link: 35117614

Variant Present in the following documents:

• tcr-09-04-2542.pdf

View BVdb publication page

Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis.

Frontiers In Oncology

Wan, Lingling L; Liu, Qingyi Q; Liang, Di D; Guo, Yongdong Y; Liu, Guangjie G; Ren, Jinxia J; He, Yutong Y; Shan, Baoen B

Publication Date: 2021

Variant appearance in text: EGFR: 1078delA

PubMed Link: 34136379

Variant Present in the following documents:

• Main text
• fonc-11-630672.pdf

View BVdb publication page

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.

Bmc Cancer

Xiao, Jian J; Li, Wenyun W; Huang, Yan Y; Huang, Mengli M; Li, Shanshan S; Zhai, Xiaohui X; Zhao, Jing J; Gao, Chan C; Xie, Wenzhuan W; Qin, Hao H; Cai, Shangli S; Bai, Yuezong Y; Lan, Ping P; Zou, Yifeng Y

Publication Date: 2021-03-16

Variant appearance in text: EGFR: 1082del; N361Tfs*35

PubMed Link: 33726687

Variant Present in the following documents:

• 12885_2021_7942_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page